Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Clinical trial NCT07226544 · RECRUITING

Trial details

NCT number: NCT07226544
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Localized Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma Stage II Renal Cell Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2026-10-01
Primary completion: 2027-09-08
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.